Allopurinol Tablets Market Report
The report on the Global Allopurinol Tablets Market is segmented By Product (100 mg, 300 mg), Application (Gout, Kidney Stones), and Region. The report also covers the COVID-19 Impact Analysis and Forecast to 2026. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Allopurinol Tablets market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The report on the Global Allopurinol Tablets Market is segmented By Product (100 mg, 300 mg), Application (Gout, Kidney Stones), and Region. The report also covers the COVID-19 Impact Analysis and Forecast to 2026.
The Global Allopurinol Tablets Market is expected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of over x% during the forecast period.
Figure: Global Allopurinol Tablets Market Size, 2020-2026 (USD Billion)
Wish to get a free sample? Register here
Allopurinol tablet is a prescribed medication used to treat high levels of uric acid which is caused by consumption of certain cancer medication. High level of uric acid can cause kidney stones or gout attacks. Allopurinol comes under the medication class of xanthine oxidase inhibitors. It is also used to treat pain caused by pancreas diseases and certain infections.
Key players operating in the global Allopurinol Tablets Market are-
The growth of the global allopurinol tablets market is primarily driven by a rise in the number of people suffering from kidney diseases.
Based on application, the market has been segmented into gout and kidney stones.
Geographically, the market in North America accounted for the largest market share in 2020 and is projected to continue its dominance during the review period.
- The market growth can be attributed to the prevalence of the large number of people suffering from obesity and cancer.
- The market in Asia-Pacific is expected to increase at a healthy CAGR during the review period on account of increasing alcohol consumption and unhealthy lifestyle which has resulted in increasing gout incidences in the region.
The covid-19 outbreak affected the market growth of the Allopurinol tablets market for a short period. The coronavirus outbreak affected the economies significantly due to the imposition of lockdown which resulted in travel restrictions and supply chain disruptions. The disruptions in the supply chain affected product availability and thus, affected the market growth.
Want to know segmentation details? Register Here
Here is the list of the group of customers that the Allopurinol tablet market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
Casper Pharma (The U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Dr. Reddys Laboratories (India), Mylan N.V. (The U.S.), Apotex Inc. (Canada), Sun Pharmaceutical Industries Limited (India), Zydus Pharmaceuticals Inc. (The U.S.), NorthStar Healthcare (The U.S.), Ipca Laboratories Limited (India), and Accord Healthcare Ltd. (India) are the key players in the allopurinol tablets market.
North America is expected to remain dominant in the allopurinol tablets market in the coming years.
The gout segment accounted for the largest share of the allopurinol tablets market in 2020.
Allopurinol tablets manufacturers, Allopurinol tablets suppliers, Allopurinol tablets distributors, Organizations, Government bodies are the target audience in the allopurinol tablets market.